Virtual Reality Combined With Bobath Therapy for Spastic Cerebral Palsy
VR-BOBATH-CP
Effects of Virtual Reality Combined With Bobath Technique on Lower Limb Muscle Activity, Balance, and Motor Function in Patients With Spastic Cerebral Palsy: A Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
Spastic cerebral palsy is a common neurodevelopmental disorder characterized by increased muscle tone, impaired balance, and limitations in motor function, particularly in the lower limbs. Conventional rehabilitation approaches such as the Bobath technique are widely used to improve posture control and movement patterns; however, patient engagement and task variability may be limited. This randomized controlled trial aims to evaluate the effectiveness of virtual reality (VR) combined with Bobath therapy on lower limb muscle activity, balance, and gross motor function in patients with spastic cerebral palsy. Eligible participants will be randomly assigned to either a VR plus Bobath intervention group or a conventional Bobath therapy group. The intervention will be delivered over a 6-week period, with sessions conducted five times per week. Outcome measures, including surface electromyography (sEMG), center of pressure (COP) parameters, and the Gross Motor Function Measure-88 (GMFM-88), will be assessed before and after the intervention. This study seeks to provide evidence on whether integrating VR into conventional rehabilitation can improve functional outcomes in children with spastic cerebral palsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedFebruary 6, 2026
February 1, 2026
2 months
January 25, 2026
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Lower Limb Muscle Activity Assessed by Surface Electromyography
Lower limb muscle activity will be assessed using surface electromyography (sEMG). The sEMG amplitude and activation patterns of the rectus femoris, biceps femoris, tibialis anterior, and soleus muscles will be recorded during standardized functional tasks.
Baseline and immediately after 6 weeks of intervention
Balance Function Assessed by Center of Pressure Parameters
Balance function will be evaluated using center of pressure (COP) measurements obtained from plantar pressure analysis. Static and dynamic balance parameters will be analyzed to assess postural control.
Baseline and immediately after 6 weeks of intervention
Gross Motor Function Measured by the Gross Motor Function Measure-88
Gross motor function will be assessed using the Gross Motor Function Measure-88 (GMFM-88). Dimension D (standing) and Dimension E (walking, running, and jumping) scores will be used for analysis.
Baseline and immediately after 6 weeks of intervention
Secondary Outcomes (4)
Overall Quality of Life Score Assessed by PedsQL Total Score
Baseline and immediately after 6 weeks of intervention
Domain-Specific Quality of Life Scores Assessed by PedsQL
Baseline and immediately after 6 weeks of intervention
Attendance Rate of Scheduled Rehabilitation Sessions
Throughout the 6-week intervention period
Completion Rate of the Rehabilitation Program
Throughout the 6-week intervention period
Study Arms (2)
Virtual Reality Combined With Bobath Therapy
EXPERIMENTALParticipants in this arm will receive immersive, task-oriented virtual reality training combined with Bobath neurodevelopmental therapy. The intervention will be delivered by experienced physical therapists for 40 minutes per session, five sessions per week, over a 6-week period.
Conventional Bobath Therapy
ACTIVE COMPARATORParticipants in this arm will receive conventional Bobath-based neurodevelopmental therapy without virtual reality components. The intervention frequency and duration will be the same as the experimental group, with 40-minute sessions conducted five times per week for 6 weeks.
Interventions
Standard Bobath-based neurodevelopmental therapy provided by experienced physical therapists, without the use of virtual reality. Sessions will last 40 minutes and will be conducted five times per week for a total duration of 6 weeks.
Immersive, task-oriented virtual reality training integrated with Bobath neurodevelopmental therapy, delivered by trained physical therapists. Each session will last 40 minutes and will be conducted five times per week for a total duration of 6 weeks.
Eligibility Criteria
You may qualify if:
- Aged 2 to 14 years at the time of enrollment.
- Diagnosed with spastic cerebral palsy (spastic diplegia or spastic hemiplegia) by a qualified clinician.
- Classified as Gross Motor Function Classification System (GMFCS) levels I to III.
- Presence of lower limb spasticity with a Modified Ashworth Scale (MAS) score of at least 1.
- Ability to understand and follow simple instructions appropriate for age and cognitive level.
- Written informed consent obtained from a parent or legal guardian.
You may not qualify if:
- Presence of severe cognitive impairment that prevents participation in the intervention or assessments.
- Uncontrolled epilepsy or a history of frequent seizures that may interfere with the intervention.
- Severe visual, vestibular, or auditory impairments that limit safe participation in virtual reality training.
- Orthopedic surgery or botulinum toxin injection involving the lower limbs within the previous 6 months.
- Participation in other interventional clinical studies during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hongxinkang New Traditional Chinese Medicine Hospital, Tongren
Tongren, Guizhou, 554300, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ning Li
Tongren Hongxin Kangxin Traditional Chinese Medicine Hospital, Guizhou Province
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 25, 2026
First Posted
February 6, 2026
Study Start
March 1, 2026
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
February 6, 2026
Record last verified: 2026-02